Search

Your search keyword '"Gold, Alex"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Gold, Alex" Remove constraint Author: "Gold, Alex" Database Unpaywall Remove constraint Database: Unpaywall
70 results on '"Gold, Alex"'

Search Results

20. Abstract 9793: Walking Performance, Quality of Life, and Hemodynamic Characteristics in Patients with Peripheral Artery Disease and End-Stage Kidney Disease (PAD-ESKD)

21. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

23. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial

26. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis

28. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis

30. Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification

31. Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

33. FP633A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE 2B STUDY TO ASSESS THE EFFECT OF SNF472 ADDED TO STANDARD OF CARE ON PROGRESSION OF CARDIOVASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HAEMODIALYSIS (CaLIPSO STUDY)

37. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy

41. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification

42. Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059)

43. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

44. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

46. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

48. 176 Andexanet Alfa

Catalog

Books, media, physical & digital resources